No abstract available
Keywords:
Immune checkpoints; new-onset DM; safety; therapy.
MeSH terms
-
Antineoplastic Agents, Immunological*
-
Attention
-
Diabetes Mellitus*
-
Humans
-
Immune Checkpoint Inhibitors
-
Immunotherapy
-
Nivolumab
Substances
-
Immune Checkpoint Inhibitors
-
Nivolumab
-
Antineoplastic Agents, Immunological